The Icahn School of Medicine at Mount Sinai and The Chemotherapy Foundation
Last Modified: April 10, 2014
Dates: November 5-7, 2014
Location: The Marriott Marquis Hotel, NYC
Sponsoring Group: The Icahn School of Medicine at Mount Sinai and The Chemotherapy Foundation
Web Page URL: chemotherapyfoundationsymposium.org
Topics Covered: Hematology, GI Sessions, Pediatric Oncology, GYN, Head and Neck, CNS, Breast Cancer,Prostate, Renal, Bladder, Lung Cancer, Personalized Therapy, Melanoma, Patient Care
Objectives: Founded in 1972 by Ezra Greenspan, we continue to bring the groundbreaking advances spearheading progress in cancer therapeutics to community and academic practitioners. Leading oncologist and hematologist investigators will report on new regimens, clinical trials and emerging therapeutic advances in common cancer types.
Who Should Attend: Physicians and other Cancer Providers (Nurses, PAs, NPs, House Staff, Fellows, Pharmacists, Industry)
Agenda: 2014 Agenda in progress. Updates can be found at: www.chemotherapyfoundationsymposium.org/CMS/programs
Registration Information: Register online at www.chemotherapyfoundationsymposium.org/CMS/
Fees: See chemotherapyfoundationsymposium.org
Continuing Education: Yes
Miscellany: This is a CME accredited educational activity jointly presented by the Icahn School of Medicine at Mount Sinai and the Chemotherapy Foundation, a non-profit organization supporting cancer research, in collaboration with The Tisch Cancer Institute.
Apr 25, 2014 - Poor kidney function, measured by a low glomerular filtration rate, is independently associated with a higher risk of incident cancer, compared to participants with preserved GFR, according to a study presented at the National Kidney Foundation's 2014 Spring Clinical Meetings, held from April 22 to 26 in Las Vegas.